Most of the moderating posts here have been well stated previously.
This is a biotech speccy well away from commercialization which will occur only after positive final results from P3 trial is on the table.
As such it is pretty much a cork in the market tempest with spikes on +ve news and dips in news vacuums which is currently holding due to the expectation of a Nasdaq listing. Which means imho that a significant portion of the effect of that listing is built into the current SP.
@Birmingham: i recall you recently copped some flak in a potash play when you made a very wrong call from your charts? What have your charts told you here that makes this a good entry point?
Most of the moderating posts here have been well stated...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 127863 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 30850 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |